Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals (RIGL)
21.92 +0.11 (+0.50%) 14:52 ET [NASDAQ]
21.82 x 200 21.96 x 200
Realtime by (Cboe BZX)
21.82 x 200 21.96 x 200
Realtime 22.00 +0.19 (+0.87%) 08:00 ET
Quote Overview for Thu, Jan 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
21.13
Day High
21.86
Open 21.57
Previous Close 21.81 21.81
Volume 80,817 80,817
Avg Vol 342,383 342,383
Stochastic %K 97.15% 97.15%
Weighted Alpha +40.13 +40.13
5-Day Change +3.76 (+20.88%) +3.76 (+20.88%)
52-Week Range 7.48 - 29.82 7.48 - 29.82
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 384,183
  • Shares Outstanding, K 17,615
  • Annual Sales, $ 116,880 K
  • Annual Income, $ -25,090 K
  • EBIT $ 10 M
  • EBITDA $ 10 M
  • 60-Month Beta 1.31
  • Price/Sales 2.43
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 71.92% ( +1.50%)
  • Historical Volatility 84.62%
  • IV Percentile 25%
  • IV Rank 32.61%
  • IV High 205.21% on 04/05/24
  • IV Low 7.41% on 10/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 66
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 1,437
  • Open Int (30-Day) 1,219

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.42
  • Number of Estimates 4
  • High Estimate 0.65
  • Low Estimate 0.13
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.63 +48.80%
on 12/24/24
Period Open: 17.15
22.06 -1.31%
on 01/22/25
+4.62 (+26.94%)
since 12/23/24
3-Month
13.57 +60.42%
on 10/31/24
Period Open: 14.59
29.82 -27.00%
on 11/12/24
+7.18 (+49.21%)
since 10/23/24
52-Week
7.48 +190.88%
on 07/05/24
Period Open: 12.70
29.82 -27.00%
on 11/12/24
+9.07 (+71.42%)
since 01/23/24

Most Recent Stories

More News
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz

The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam.

AVXL : 9.99 (+0.55%)
RIGL : 21.92 (+0.50%)
NVAX : 9.34 (+5.78%)
Small-Cap Stocks Can Outperform Large-Cap Peers in 2025: 5 Top Picks

U.S. stock markets witnessed an impressive rally in 2024 after an astonishing bull run in 2023. Following the 24.2% ascent in 2023, the S&P 500 rallied 23.3% last year. The Dow and the Nasdaq Composite...

LIND : 11.66 (+1.83%)
TZOO : 20.65 (+1.08%)
RIGL : 21.92 (+0.50%)
GHM : 46.90 (-0.11%)
EVER : 17.95 (-1.48%)
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

Genomics companies analyze and interpret genetic information to uncover insights about genetic variations and disease mechanisms and develop tests, therapies and technologies to advance personalized medicine. Companies...

IMCR : 32.21 (+3.84%)
CRSP : 43.70 (-1.13%)
GLUE : 5.48 (-0.90%)
CSTL : 26.35 (-1.01%)
RIGL : 21.92 (+0.50%)
3 Ways to Invest in Small-Cap Stocks Now

With small-cap stocks surging in response to Donald Trump's re-election and the Federal Reserve's rate cut, investors can tap into this momentum through three distinct ETFs: VBK, DWAS, and UWM, each offering...

TRGP : 211.45 (+0.09%)
LMB : 104.27 (-0.36%)
MOD : 143.81 (+0.79%)
DRS : 37.27 (+0.65%)
DWAS : 95.05 (-0.17%)
AXON : 609.48 (+0.31%)
UWM : 44.71 (+0.47%)
LII : 665.95 (+0.40%)
DECK : 217.27 (+1.09%)
RIGL : 21.92 (+0.50%)
STRL : 195.80 (-2.37%)
VBK : 295.43 (+0.25%)
Rigel: Q3 Earnings Snapshot

Rigel: Q3 Earnings Snapshot

RIGL : 21.92 (+0.50%)
Rigel: Q2 Earnings Snapshot

Rigel: Q2 Earnings Snapshot

RIGL : 21.92 (+0.50%)
Rigel: Q1 Earnings Snapshot

Rigel: Q1 Earnings Snapshot

RIGL : 21.92 (+0.50%)
Rigel: Q3 Earnings Snapshot

Rigel: Q3 Earnings Snapshot

RIGL : 21.92 (+0.50%)
Rigel Announces Presentation at the Upcoming IDWeek 2023

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced an upcoming oral presentation highlighting data from the FOCUS Phase 3 clinical...

RIGL : 21.92 (+0.50%)
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel's Inducement Plan, approved...

RIGL : 21.92 (+0.50%)

Business Summary

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year....

See More

Key Turning Points

3rd Resistance Point 23.64
2nd Resistance Point 22.85
1st Resistance Point 22.33
Last Price 21.92
1st Support Level 21.02
2nd Support Level 20.23
3rd Support Level 19.71

See More

52-Week High 29.82
Last Price 21.92
Fibonacci 61.8% 21.29
Fibonacci 50% 18.65
Fibonacci 38.2% 16.02
52-Week Low 7.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar